Tiziana Life Sciences
TLSA
5 hedge funds and large institutions have $3.89M invested in Tiziana Life Sciences in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
36% more capital invested
Capital invested by funds: $2.87M → $3.89M (+$1.02M)
0.84% more ownership
Funds ownership: 1.41% → 2.25% (+0.84%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$1.29M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$81.5K |
| 3 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$58K |
| 4 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
HighTower Advisors
Chicago,
Illinois
| $3.58M | +$1.29M | +1,040,084 | +54% |
|
|
HAG
2
HighPoint Advisor Group
Downers Grove,
Illinois
| $221K | +$58K | +46,956 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $80K | +$81.5K | +65,924 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | -$4.32K | -3,499 | -32% |
|
|
TCM
5
Tradewinds Capital Management
Bellingham,
Washington
| – | +$12 | +10 | +11% |
|
TLSA Hedge Fund Activity: Q1 2019 in Review
5 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2019, worth a combined $3.89M — up 36% from $2.87M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TLSA positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $1.29M. The largest seller was UBS Group, cutting an estimated $4.32K.
- 5 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2019, up from 3 in Q4 2018.
- Funds reported $3.89M of Tiziana Life Sciences stock for Q1 2019, up 36% quarter-over-quarter.
- 2 funds opened new Tiziana Life Sciences positions in Q1 2019 and 0 closed out, a net change of +2 holders.
- The largest Tiziana Life Sciences buyer in Q1 2019 was HighTower Advisors, an estimated $1.29M added.
- The largest Tiziana Life Sciences seller in Q1 2019 was UBS Group, an estimated $4.32K sold.
Based on aggregated 13F filings for Q1 2019.